Quarterly Results

202605 Results Summary

Revenue

The revenue stands at ₹ crore, reflecting a quarter-on-quarter *(QoQ) decrease of per cent from ₹ crore. This corresponds to a year-on-year *(YoY) decline of per cent.

Operating Profit

Operating Profit stands at ₹ crore, reflecting a quarter-on-quarter *(QoQ) decrease of per cent from ₹ crore. This corresponds to a year-on-year *(YoY) decline of per cent.

PBDT

PBDT stands at ₹ crore, reflecting a quarter-on-quarter *(QoQ) decrease of per cent from ₹ crore. This corresponds to a year-on-year *(YoY) decline of per cent.

Profit Before Tax

Profit Before Tax stands at ₹ crore, reflecting a quarter-on-quarter *(QoQ) decrease of per cent from ₹ crore. This corresponds to a year-on-year *(YoY) decline of per cent.

Net Profit

Net Profit stands at ₹ crore, reflecting a quarter-on-quarter *(QoQ) decrease of per cent from ₹ crore. This represents a per cent year-on-year *(YoY) decline for the same year.

  • YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.

Company News

More

Earnings

CategoryQ4 FY25-26Q4 FY24-25Change %FY25-26FY24-25Change %
Total Revenue6,541.206,729.69-2.8028,162.5927,547.622.23
Expenses5,586.255,192.107.5922,555.6020,419.7210.46
Other Income148.16289.46-48.82882.01861.872.34
Operating Profit954.951,537.59-37.896,489.007,989.77-18.78
Depreciation382.92308.7324.031,210.981,106.959.40
Interest13.1314.02-6.3554.3962.01-12.29
Profit Before Tax699.461,493.42-53.165,223.636,820.81-23.42
Tax156.95279.28-43.801,440.951,708.35-15.65
Net Profit542.511,214.14-55.323,869.795,291.05-26.86
CategoryQ4 FY25-26Q3 FY25-26Change %
Total Revenue6,541.207,074.48-7.54
Expenses5,586.256,095.33-8.35
Other Income148.16206.34-28.20
Operating Profit954.95979.15-2.47
Depreciation382.92278.3537.57
Interest13.1314.03-6.41
Profit Before Tax699.46892.80-21.66
Tax156.95218.55-28.19
Net Profit542.51674.25-19.54

Research Reports

ActionTarget Price (₹)BrokerDateReports
Data Not Found

Financial Reports

Data not available.

Stock Prices Compare with Peers

Company1 Day1 Week1 Month3 Months6 Month1 Year
Data Not Found

Corporate Information

Company News

Nifty Healthcare below 100-WMA, down 8% from its peak; what charts say?

Amol Athawale of Kotak Securities believes that the short-term outlook for Nifty Healthcare remains uncertain and sentiment may turn negative in case the index falls below 13,500 levels.

Updated On: 06 Apr 2026 | 11:19 AM IST

Trading guide: Nifty eyes 23,200; BSE, Laurus Labs, Cipla on analyst radar

Stocks to buy: Ajit Mishra of Religare Broking recommends buying BSE and Laurus Labs; also suggests Nifty trading strategy

Updated On: 02 Apr 2026 | 6:37 AM IST

Cipla tanks 20% so far in CY 2026; hits over 2-year low in firm market

Cipla declined 2% to ₹1,195.15, also its lowest level since December 2023 on the BSE in Wednesday's intra-day trade.

Updated On: 01 Apr 2026 | 2:58 PM IST

Focus on "stock-specific" opportunities: Analyst; suggests 2 stocks to buy

Ajit Mishra of Religare Broking recommends buying Cummins India, Granules and selling Cipla futures; check all details here

Updated On: 19 Mar 2026 | 7:37 AM IST

Stocks to Watch today: Adani Power, Acme Solar, Dixon Tech, Minda Corp

Stocks to watch today, March 10, 2026: Cochin Shipyard, Hyundai Motor India, Motilal Oswal, Vishal Mega Mart, Torrent Power, Minda Corp, and Alembic Pharma are among the top stocks to remain in focus

Updated On: 10 Mar 2026 | 7:03 AM IST

Stocks to Watch: Dabur, Adani Ports, Cipla, JSW Cement, Allied Blenders

Stocks to Watch today: Dabur, Adani Ports, Cipla, JSW Cement, Allied Blenders, IOL Chemicals and MAS Financial are among the stocks to watch today, March 04, 2026

Updated On: 04 Mar 2026 | 7:52 AM IST

Nifty Pharma index soars 7% thus far in February; nears 52-week high

Thus far in the month of February 2026, Laurus Labs surged 13%, while Sun Pharmaceutical Industries and Torrent Pharmaceuticals soared 11% each.

Updated On: 26 Feb 2026 | 3:01 PM IST

Pharma stocks in demand; Torrent hits new high; Natco up 6% on huge volumes

At 01:13 PM on Tuesday; Nifty Pharma index, the top gainer among sectoral indices, was up 0.2 per cent, as compared to 1.1 per cent decline in the Nifty 50.

Updated On: 24 Feb 2026 | 1:59 PM IST

Cipla shares drop 2% after US FDA designates its Greece facility as OAI

Cipla share price fell 2.4 per cent to the day's low of ₹1,335.90 per share on the National Stock Exchange (NSE)

Updated On: 23 Feb 2026 | 1:08 PM IST

US market remained a drag for Indian pharma in Q3 amid pricing pressure

The US market stayed a weak spot for Indian pharma companies in Q3FY26 amid sustained pricing pressure in generics, heightened competition and product-specific challenges

Updated On: 08 Feb 2026 | 1:58 PM IST
More